Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
7.69
+0.29 (3.92%)
At close: Jun 26, 2026, 4:00 PM EDT
7.66
-0.03 (-0.39%)
After-hours: Jun 26, 2026, 7:49 PM EDT
Xeris Biopharma Holdings Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Xeris Biopharma Holdings stock has a consensus rating of "Strong Buy" and an average price target of $11.29. The average 1-year stock price forecast is 46.81% higher than the current stock price, while the lowest is $8.00 (+4.03%) and the highest is $18 (+134.07%).
Price Target: $11.29 (+46.81%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 14, 2026.
Analyst Ratings
The average analyst rating for Xeris Biopharma Holdings stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 11, 2026 |
| Barclays | Barclays | Buy Reiterates $9 | Buy | Reiterates | $9 | +17.04% | May 14, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Reiterates $18 | Buy | Reiterates | $18 | +134.07% | May 8, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $10 | Buy | Reiterates | $10 | +30.04% | May 8, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $10 | Buy | Maintains | $10 | +30.04% | Jan 9, 2026 |
Financial Forecast
Revenue This Year
385.99M
from 291.85M
Increased by 32.26%
Revenue Next Year
472.82M
from 385.99M
Increased by 22.50%
EPS This Year
0.14
EPS Next Year
0.40
from 0.14
Increased by 177.19%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 389.5M | ||
| Avg | 386.0M | ||
| Low | 383.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 33.5% | ||
| Avg | 32.3% | ||
| Low | 31.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.19 | ||
| Avg | 0.14 | ||
| Low | 0.10 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |